linezolid
Generic: linezolid
Labeler: sandoz incDrug Facts
Product Profile
Brand Name
linezolid
Generic Name
linezolid
Labeler
sandoz inc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
linezolid 200 mg/100mL
Manufacturer
Identifiers & Regulatory
Product NDC
0781-3431
Product ID
0781-3431_731258b6-fb75-4612-b7e6-cfec8f312aaf
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA200904
Listing Expiration
2026-12-31
Marketing Start
2016-06-15
Pharmacologic Class
Established (EPC)
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
07813431
Hyphenated Format
0781-3431
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
linezolid (source: ndc)
Generic Name
linezolid (source: ndc)
Application Number
ANDA200904 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/100mL
Packaging
- 16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 Injection Linezolid intravenous injection is available in single-dose, ready-to-use flexible plastic infusion bags in a foil laminate overwrap. The infusion bags and ports are not made with natural rubber latex. The infusion bags are available in the following package sizes: NDC 0781-3431-46 100 mL bag (200 mg linezolid) NDC 0781-3431-95 pack of 10 x 100 mL bags (200 mg linezolid) NDC 0781-3433-46 300 mL bag (600 mg linezolid) NDC 0781-3433-95 pack of 10 x 300 mL bags (600 mg linezolid) 16.4 Storage and Handling Store at 20° to 25°C (68° to 77°F). Protect from light. It is recommended that the infusion bags be kept in the overwrap until ready to use. Protect infusion bags from freezing.
- Principal Display Panel NDC 0781-3431-46 Linezolid Injection-Switzerland 200 mg/100 mL For Intravenous Use 200mglabelforswitzerland
- Principal Display Panel NDC 0781-3433-46 Linezolid Injection-Switzerland 600 mg/300 mL For Intravenous Use label
Packages (0)
No package records.
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "731258b6-fb75-4612-b7e6-cfec8f312aaf", "openfda": {"nui": ["N0000175495", "M0361132"], "upc": ["0307813431466"], "unii": ["ISQ9I6J12J"], "rxcui": ["1662278", "1662285"], "spl_set_id": ["a287cdf4-47a8-459f-8890-86181af5e836"], "pharm_class_cs": ["Oxazolidinones [CS]"], "pharm_class_epc": ["Oxazolidinone Antibacterial [EPC]"], "manufacturer_name": ["Sandoz Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [], "brand_name": "Linezolid", "product_id": "0781-3431_731258b6-fb75-4612-b7e6-cfec8f312aaf", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Oxazolidinone Antibacterial [EPC]", "Oxazolidinones [CS]"], "product_ndc": "0781-3431", "generic_name": "Linezolid", "labeler_name": "Sandoz Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Linezolid", "active_ingredients": [{"name": "LINEZOLID", "strength": "200 mg/100mL"}], "application_number": "ANDA200904", "marketing_category": "ANDA", "marketing_start_date": "20160615", "listing_expiration_date": "20261231"}